Study of SPG601 in Adult Men With Fragile X Syndrome

Clinical trial NCT06413537 · COMPLETED

Trial details

NCT number: NCT06413537
Sponsor: Spinogenix
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fragile X Syndrome

Start date: 2024-07-05
Primary completion: 2024-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.